Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Normal or Varying Degrees of Impaired Renal Function
Crossref DOI link: https://doi.org/10.1007/s40268-014-0066-4
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mayer, Michael
Nudurupati, Sai
Peng, Xuejun
Marcinak, John
License valid from 2014-11-06